TIERMODELLE UND THERAPEUTISCHE MOLEKÜLE

Patent europeic · EP4215043 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4215043
Numer da la dumonda
EP23161385
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-07-2010
Publitgà
26-07-2023
Concedì
06-05-2026
La protecziun finescha il pli tard
06-07-2030
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
A01K 67/0278 (2024.01)
A01K 67/0275 (2024.01)
A61P 37/02 (2006.01)
C07K 16/00 (2006.01)
C07K 16/12 (2026.01)
C07K 16/18 (2006.01)
C07K 16/46 (2006.01)
C12N 15/85 (2006.01)
Prioritad
GB 0911846 08.07.2009
US 22396009 P 08.07.2009
GB 0913102 28.07.2009
US 35566610 P 17.06.2010
Derivà da
EP21169076
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 06-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.05.2026

Partidas

Possessur

Kymab Limited

The Bennet Building (B930) Babraham Research Campus, Cambridge CB22 3AT, GB

Inventur

BRADLEY, Allan

Cambridge, CB22 3AT, GB

LEE, E-Chiang

Cambridge, CB22 3AT, GB

LIANG, Qi

Cambridge, CB22 3AT, GB

WANG, Wei

Cambridge, CB22 3AT, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.